{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:55:21Z","timestamp":1784847321762,"version":"3.55.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Malignant peripheral nerve sheath tumors (MPNST) are a severe complication of neurofibromatosis type 1 (NF1). The median age at diagnosis is 47.1 years in the general population, whereas NF1-associated cases present significantly earlier, at 33.9 years. The incidence is 1.46 per million in the general population and 0.56 per million in children, with a higher occurrence in late adolescence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>A 3-year-old girl was referred for a recurrent soft-tissue mass in her left wrist. Imaging suggested a neurofibroma. After excision, pathological analysis and genetic testing revealed a germline <jats:italic>NF1<\/jats:italic> mutation, confirming Neurofibromatosis type 1 (NF1), along with somatic mutations in <jats:italic>NF1<\/jats:italic> and deletions in <jats:italic>CDKN2A<\/jats:italic>. Pathology confirmed malignant Triton tumor (MTT). She received six cycles of ifosfamide and doxorubicin, followed by a second excision, which showed persistent tumor activity. Positron emission tomography\u2013computed tomography (PET-CT) scans revealed reduced metabolic activity at the tumor site, suggesting a partial response to treatment. The patient is currently undergoing oral MEK inhibitor-targeted therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case highlights the challenges associated with MPNST in pediatric NF1. Both surgery and chemotherapy have been shown to enhance outcomes. Ongoing monitoring is crucial, and additional research on MEK inhibitors and genetic profiling is imperative for tailoring treatment strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1609477","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:21:28Z","timestamp":1750742488000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Malignant peripheral nerve sheath tumor in early childhood: a case report of a diagnostic challenge"],"prefix":"10.3389","volume":"15","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1038\/s41467-023-38432-6","article-title":"Multiplatform molecular profiling uncovers two subgroups of Malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities","volume":"14","author":"Suppiah","year":"2023","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25149","article-title":"Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population","volume":"61","author":"Bates","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e210945","DOI":"10.1001\/jamanetworkopen.2021.0945","article-title":"Comparison of cancer prevalence in patients with neurofibromatosis Type 1 at an academic Cancer Center vs in the general population from 1985 to 2020","volume":"4","author":"Landry","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2300597","DOI":"10.1200\/PO.23.00597","article-title":"NF1-driven rhabdomyosarcoma phenotypes: A comparative clinical and molecular study of NF1-mutant rhabdomyosarcoma and NF1-associated Malignant triton tumor","volume":"8","author":"de Traux de Wardin","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa131","article-title":"Histopathologic findings in Malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival","volume":"2","author":"Lucas","year":"2020","journal-title":"Neurooncol Adv"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz095","article-title":"Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and Malignant transformation","volume":"28","author":"Rhodes","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1978-7","article-title":"Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience","volume":"19","author":"Stucky","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae067","article-title":"Current state of spinal nerve sheath tumor management and future advances","volume":"6","author":"Gui","year":"2024","journal-title":"Neurooncol Adv"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30334-0","article-title":"Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial","volume":"18","author":"Gronchi","year":"2017","journal-title":"Lancet Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.01034","article-title":"ReNeu: A pivotal, Phase IIb trial of mirdametinib in adults and children with symptomatic neurofibromatosis type 1-associated plexiform neurofibroma","volume":"43","author":"Moertel","year":"2025","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1589","DOI":"10.1002\/ctm2.1589","article-title":"Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: the primary analysis of a phase 1 open-label study","volume":"14","author":"Wang","year":"2024","journal-title":"Clin Transl Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3760","article-title":"The need for new treatments targeting MPNST: the potential of strategies combining MEK inhibitors with antiangiogenic agents","volume":"28","author":"Gonz\u00e1lez-Mu\u00f1oz","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201178","article-title":"Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging","volume":"15","author":"Zindy","year":"1997","journal-title":"Oncogene"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0786","article-title":"Genomic patterns of Malignant peripheral nerve sheath tumor (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA","volume":"13","author":"Cortes-Ciriano","year":"2023","journal-title":"Cancer Discov"},{"key":"B17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41389-018-0056-4","article-title":"CDKN2A inhibits formation of homotypic cell-in-cell structures","volume":"7","author":"Liang","year":"2018","journal-title":"Oncogenesis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2004.02.001","article-title":"The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3","volume":"14","author":"Cao","year":"2004","journal-title":"Curr Opin Genet Dev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41418-020-00645-3","article-title":"p53-dependent elimination of aneuploid mitotic offspring by entosis","volume":"28","author":"Liang","year":"2021","journal-title":"Cell Death Differ"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae235","article-title":"Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1","volume":"27","author":"Lucas","year":"2025","journal-title":"Neuro Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1609477\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:21:29Z","timestamp":1750742489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1609477\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":20,"alternative-id":["10.3389\/fonc.2025.1609477"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1609477","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1609477"}}